Imperva (IMPV) Tops Q4 EPS by 5c, Q1 & FY16 Guidance Falls Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Needham & Company Reiterates Buy Following Imperva's (IMPV) 4Q Beat and Raise
February 4, 2016 6:45 AM ESTNeedham & Company maintained a Buy rating on Imperva (NYSE: IMPV), and cut the price target to $56.00 (from $88.00), following the company's 4Q earnings report. IMPVs $72.7m and $0.20 was comfortably above $68.1m and $0.15 EPS consensus, yet investor expectations were high going into earnings. CY16 old guidance was for $285m, and last night IMPV revised... More
